tirzepatide gip analog GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica Tirzepatide modulates the regulation of
Description
If you need to discontinue, taper down through the dose levels in reverse, spending 2-4 weeks at each step

GLP-1,GIP,injection,tirzepatide,compounded Compounded tirzepatide is a weekly injection that activates two of the body's key metabolic hormones at once GLP-1 and GIP to reduce hunger and support sustained weight loss

I need a higher dosage after a month, so I cant wait to try the next one

In a 72-week Zepbound (tirzepatide) study of adults without diabetes, average weight loss was 15.0% (34 lbs.) for 5 mg, 19.5% (44 lbs) for 10 mg, 20.9% (48 lbs.) for 15 mg, and 3.1% (7 lbs.) for placebo

According to the FDA submission for Wegovy approval (the weight loss medication produced by NovoNordisk that contains the active ingredient semaglutide), the average weight loss over 1 year and 4 months was 15.1%
